{
    "clinical_study": {
        "@rank": "4908", 
        "acronym": "ARDS", 
        "biospec_descr": {
            "textblock": "Plasma, Cell, BALF, Urine"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The goal of this project is to find a marker expression that the investigators can use to\n      trace symptom progression and develop a more efficient therapy to enhance ARDS patient\n      survival rate and better post-ICU life quality."
        }, 
        "brief_title": "Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "ARDS", 
            "Multi-organ Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Multiple Organ Failure", 
                "Respiratory Distress Syndrome, Adult", 
                "Lung Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators will first identify acute respiratory distress syndrome (ARDS) patients\n      receiving ECMO support in ICU at National Taiwan University Hospital, and then collect\n      blood, urine and bronchioalveolar lavage fluid (BALF) samples at different time points:\n      before setting up ECMO, 2, 6, 12, 24, 72 hours,5 and 14 days after ECMO installment, time to\n      wean ECMO and the day removing ECMO and leaving ICU. From the samples, the free radicals,\n      cytokines (IL-1, IL-6, IL-8, IL-18,tumor necrosis factor-\u03b1, transforming growth factor-\u03b2),\n      and inflammasome- related markers, immune cell responses and other biochemical markers would\n      be measured. The novel biomarkers to predict the outcome of the patient will be identified."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. >18 years old\n\n          2. ARDS, needing ECMO support\n\n        Exclusion Criteria:\n\n          1. pre-existing sepsis\n\n          2. pre-existing chronic renal failure (dialysis dependent), liver failure other diseases\n             precluding chance of survival."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are admitted to National Taiwan University Hospital for acute respiratory\n        distress syndrome needing ECMO placement."
            }
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01967602", 
            "org_study_id": "201103056RB"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute respiratory distress syndrome (ARDS)", 
            "Extracorporeal membrane oxygenation (ECMO)", 
            "biomarker"
        ], 
        "lastchanged_date": "October 22, 2013", 
        "location": {
            "contact": {
                "email": "shuenn@ntuh.gov.tw", 
                "last_name": "Shuenn-Wen Kuo, MD", 
                "phone": "0972651448"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan"
                }, 
                "name": "National Taiwan University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support", 
        "overall_official": {
            "affiliation": "National Taiwan University Hospital", 
            "last_name": "Shuenn-Wen Kuo, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients who survived for more than 7 days after ECMO treatment were defined as survival, and non-survival patients were defined as expired or multiple organ failure incompatible with life within 7 days after ECMO installation.", 
            "measure": "Mortality or multi-organ failure", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01967602"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}